Rodman David Malcom's Stock Transactions in Mineralys Therapeutics, Inc.

The filing details the stock transactions of Rodman David Malcom, an officer at Mineralys Therapeutics, Inc. Malcom exercised employee stock options on October 11, 2024, acquiring 5,017 shares of common stock, and on October 14, 2024, acquiring an additional 5,352 shares. These transactions were executed for cash. Additionally, Malcom sold 11,365 shares on August 13, 2025, for $146,987.47, and 11,367 shares on September 15, 2025, for $409,266.28. The filing also notes that Malcom plans to sell 10,369 shares on October 15, 2025, with an aggregate market value of $445,982.61. The transactions were conducted through Merrill Lynch on the NASDAQ exchange.